 Matthew Galbraith
Concepts (278)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 14 | 2025 | 506 | 2.130 |
Why?
| | Cyclin-Dependent Kinase 8 | 8 | 2025 | 51 | 1.810 |
Why?
| | Cyclin-Dependent Kinases | 8 | 2025 | 131 | 1.490 |
Why?
| | Interferons | 6 | 2025 | 195 | 1.370 |
Why?
| | Transcriptome | 7 | 2025 | 1003 | 1.200 |
Why?
| | Tumor Suppressor Protein p53 | 9 | 2023 | 528 | 1.170 |
Why?
| | Transcription, Genetic | 9 | 2021 | 1487 | 1.100 |
Why?
| | Transcriptional Activation | 9 | 2023 | 378 | 0.990 |
Why?
| | Mediator Complex | 3 | 2013 | 61 | 0.850 |
Why?
| | Proteome | 4 | 2025 | 483 | 0.740 |
Why?
| | Blood | 1 | 2022 | 113 | 0.710 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2024 | 286 | 0.680 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.680 |
Why?
| | Neoplasms | 8 | 2023 | 2741 | 0.670 |
Why?
| | Protein Kinase Inhibitors | 3 | 2025 | 914 | 0.620 |
Why?
| | Genomics | 2 | 2021 | 814 | 0.580 |
Why?
| | RNA Polymerase II | 7 | 2019 | 339 | 0.530 |
Why?
| | Signal Transduction | 10 | 2025 | 5144 | 0.530 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 2166 | 0.510 |
Why?
| | Cell Hypoxia | 2 | 2017 | 231 | 0.500 |
Why?
| | ets-Domain Protein Elk-1 | 2 | 2013 | 12 | 0.490 |
Why?
| | Mitogens | 2 | 2013 | 59 | 0.480 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 175 | 0.450 |
Why?
| | Serum Response Element | 2 | 2011 | 6 | 0.420 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 23 | 0.400 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1242 | 0.330 |
Why?
| | Hypoxia | 4 | 2024 | 1164 | 0.320 |
Why?
| | Humans | 50 | 2025 | 141187 | 0.320 |
Why?
| | Anemia, Sickle Cell | 2 | 2023 | 266 | 0.310 |
Why?
| | Eosinophilic Esophagitis | 2 | 2024 | 326 | 0.300 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2021 | 1431 | 0.260 |
Why?
| | Nuclear Proteins | 4 | 2023 | 712 | 0.260 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3469 | 0.260 |
Why?
| | Glutamine | 2 | 2023 | 107 | 0.250 |
Why?
| | Apoptosis | 7 | 2025 | 2574 | 0.250 |
Why?
| | Cell Proliferation | 6 | 2023 | 2504 | 0.250 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 325 | 0.240 |
Why?
| | Animals | 18 | 2025 | 37657 | 0.240 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 511 | 0.240 |
Why?
| | Human Development | 1 | 2025 | 22 | 0.230 |
Why?
| | Pantoea | 1 | 2004 | 2 | 0.220 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2025 | 159 | 0.220 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2004 | 7 | 0.220 |
Why?
| | Phenazines | 1 | 2004 | 12 | 0.220 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1478 | 0.220 |
Why?
| | Datasets as Topic | 2 | 2022 | 125 | 0.220 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 27 | 0.220 |
Why?
| | Immunoglobulins | 1 | 2025 | 168 | 0.220 |
Why?
| | Erythropoiesis | 1 | 2024 | 56 | 0.220 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2024 | 42 | 0.210 |
Why?
| | Heme | 1 | 2024 | 76 | 0.210 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.210 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 144 | 0.210 |
Why?
| | HCT116 Cells | 3 | 2019 | 80 | 0.210 |
Why?
| | Liposarcoma | 1 | 2023 | 27 | 0.200 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 200 | 0.200 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 13 | 0.200 |
Why?
| | Piperidines | 1 | 2024 | 216 | 0.200 |
Why?
| | Hematopoiesis | 2 | 2021 | 194 | 0.200 |
Why?
| | Cell Line | 4 | 2025 | 2885 | 0.200 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2023 | 168 | 0.190 |
Why?
| | HeLa Cells | 3 | 2013 | 640 | 0.190 |
Why?
| | Fibroblasts | 2 | 2019 | 1020 | 0.190 |
Why?
| | Proteomics | 3 | 2025 | 1134 | 0.190 |
Why?
| | Metabolome | 2 | 2025 | 366 | 0.180 |
Why?
| | Transcription Factors | 3 | 2023 | 1703 | 0.180 |
Why?
| | Imidazoles | 2 | 2020 | 244 | 0.180 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 179 | 0.180 |
Why?
| | Enteritis | 1 | 2022 | 105 | 0.180 |
Why?
| | Pyrimidines | 1 | 2024 | 477 | 0.170 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 31 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2023 | 218 | 0.170 |
Why?
| | Cell Differentiation | 3 | 2024 | 2003 | 0.170 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 464 | 0.170 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 202 | 0.170 |
Why?
| | Autoimmunity | 2 | 2024 | 908 | 0.170 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 82 | 0.170 |
Why?
| | Erythrocytes | 2 | 2023 | 699 | 0.170 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 166 | 0.170 |
Why?
| | Glycolysis | 2 | 2024 | 321 | 0.170 |
Why?
| | Case-Control Studies | 3 | 2025 | 3588 | 0.160 |
Why?
| | Oncogenes | 1 | 2021 | 118 | 0.160 |
Why?
| | Piperazines | 2 | 2020 | 354 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 242 | 0.160 |
Why?
| | RNA Helicases | 1 | 2020 | 31 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2025 | 788 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 66 | 0.160 |
Why?
| | Alzheimer Disease | 1 | 2025 | 583 | 0.150 |
Why?
| | Biomarkers | 4 | 2025 | 4174 | 0.150 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 313 | 0.140 |
Why?
| | Interferon-alpha | 1 | 2019 | 196 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 63 | 0.140 |
Why?
| | Mice | 10 | 2024 | 18048 | 0.140 |
Why?
| | Epithelial Cells | 1 | 2024 | 1110 | 0.140 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 13 | 0.140 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 27 | 0.140 |
Why?
| | Hexokinase | 1 | 2017 | 17 | 0.140 |
Why?
| | Complement Activation | 1 | 2021 | 415 | 0.140 |
Why?
| | Complement System Proteins | 1 | 2021 | 333 | 0.140 |
Why?
| | Deoxyglucose | 1 | 2017 | 51 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 507 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 444 | 0.130 |
Why?
| | Homeostasis | 1 | 2021 | 636 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 377 | 0.130 |
Why?
| | Gene Editing | 1 | 2017 | 86 | 0.130 |
Why?
| | Lysine Acetyltransferase 5 | 1 | 2016 | 2 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2017 | 73 | 0.130 |
Why?
| | Neurons | 1 | 2025 | 1619 | 0.130 |
Why?
| | Purines | 1 | 2017 | 179 | 0.130 |
Why?
| | Acetylation | 2 | 2016 | 245 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 189 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 440 | 0.120 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 200 | 0.120 |
Why?
| | Interferon-gamma | 1 | 2019 | 792 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1662 | 0.120 |
Why?
| | Conserved Sequence | 1 | 2016 | 238 | 0.120 |
Why?
| | Histone Acetyltransferases | 1 | 2016 | 62 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 149 | 0.120 |
Why?
| | Tretinoin | 1 | 2016 | 122 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 875 | 0.110 |
Why?
| | Down-Regulation | 1 | 2017 | 641 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1892 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 601 | 0.110 |
Why?
| | HEK293 Cells | 2 | 2016 | 737 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 253 | 0.110 |
Why?
| | DNA Helicases | 1 | 2016 | 140 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 400 | 0.110 |
Why?
| | Drosophila Proteins | 1 | 2016 | 204 | 0.110 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 237 | 0.110 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1251 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1865 | 0.100 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 25 | 0.100 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 18 | 0.100 |
Why?
| | Phosphorylation | 2 | 2019 | 1768 | 0.100 |
Why?
| | Female | 14 | 2025 | 75515 | 0.100 |
Why?
| | Genes, ras | 1 | 2013 | 95 | 0.100 |
Why?
| | Models, Biological | 1 | 2021 | 1828 | 0.100 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2013 | 70 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 642 | 0.100 |
Why?
| | Protein Binding | 4 | 2021 | 2239 | 0.100 |
Why?
| | Child, Preschool | 5 | 2025 | 11457 | 0.100 |
Why?
| | Child | 7 | 2025 | 22308 | 0.100 |
Why?
| | Adult | 9 | 2025 | 39177 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1073 | 0.090 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2012 | 11 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2025 | 2599 | 0.090 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 30 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 54 | 0.090 |
Why?
| | Histones | 2 | 2016 | 639 | 0.090 |
Why?
| | Adolescent | 6 | 2025 | 22007 | 0.090 |
Why?
| | Young Adult | 5 | 2025 | 13673 | 0.080 |
Why?
| | Hospitalization | 1 | 2021 | 2255 | 0.080 |
Why?
| | Gene Silencing | 2 | 2023 | 196 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 3 | 2023 | 623 | 0.080 |
Why?
| | Yeasts | 1 | 2010 | 52 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2016 | 852 | 0.080 |
Why?
| | Gene Expression Profiling | 3 | 2024 | 1764 | 0.080 |
Why?
| | Phenotype | 3 | 2023 | 3166 | 0.080 |
Why?
| | MCF-7 Cells | 2 | 2020 | 126 | 0.070 |
Why?
| | Male | 9 | 2025 | 69783 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 14 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2250 | 0.070 |
Why?
| | Middle Aged | 6 | 2025 | 34434 | 0.070 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 674 | 0.060 |
Why?
| | Cytokines | 2 | 2024 | 2098 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2023 | 624 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 898 | 0.060 |
Why?
| | Tumor Cells, Cultured | 2 | 2019 | 959 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 62 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 60 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 112 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2560 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 66 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 65 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 2004 | 166 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2023 | 3068 | 0.050 |
Why?
| | Cell Death | 1 | 2025 | 386 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2025 | 4404 | 0.050 |
Why?
| | Hydroxyurea | 1 | 2023 | 36 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 62 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 210 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 21 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 98 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Proline | 1 | 2023 | 76 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 52 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2004 | 339 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 228 | 0.050 |
Why?
| | Sphingosine | 1 | 2023 | 45 | 0.050 |
Why?
| | Kynurenine | 1 | 2023 | 118 | 0.050 |
Why?
| | Lysophospholipids | 1 | 2023 | 80 | 0.050 |
Why?
| | Cyclins | 1 | 2022 | 92 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2021 | 2828 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 151 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 87 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 161 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 257 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 67 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 4013 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 201 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 824 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 454 | 0.040 |
Why?
| | Infant | 2 | 2025 | 9818 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 44 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 325 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 118 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 24 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.040 |
Why?
| | Escherichia coli | 1 | 2004 | 838 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2929 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2020 | 77 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 97 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 71 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 149 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 420 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 88 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 213 | 0.040 |
Why?
| | Biomedical Research | 1 | 2025 | 703 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 367 | 0.030 |
Why?
| | Up-Regulation | 1 | 2021 | 859 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 423 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 908 | 0.030 |
Why?
| | Cell Survival | 1 | 2021 | 1129 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1470 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 600 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5629 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 432 | 0.030 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 2016 | 10 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2180 | 0.030 |
Why?
| | Promyelocytic Leukemia Protein | 1 | 2016 | 5 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 2016 | 16 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 372 | 0.030 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 33 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2016 | 31 | 0.030 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2016 | 44 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 196 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 301 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1274 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 136 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 704 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1197 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 232 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 405 | 0.030 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2016 | 103 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 425 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1970 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 626 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2025 | 7856 | 0.030 |
Why?
| | Monocytes | 1 | 2016 | 579 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2793 | 0.020 |
Why?
| | Quality of Life | 1 | 2025 | 2999 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 7739 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 529 | 0.020 |
Why?
| | Caspase 8 | 1 | 2012 | 48 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 194 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1316 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 464 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 830 | 0.020 |
Why?
| | Protein Transport | 1 | 2012 | 448 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4073 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5200 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4208 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5887 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2008 | 29 | 0.020 |
Why?
| | Genes, fos | 1 | 2008 | 37 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 2002 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 225 | 0.020 |
Why?
| | RNA | 1 | 2014 | 930 | 0.020 |
Why?
| | Aged | 1 | 2025 | 24574 | 0.010 |
Why?
| | Mitochondria | 1 | 2012 | 967 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2008 | 609 | 0.010 |
Why?
|
|
Galbraith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|